Medical Supply Chain Resiliency Act; Promotion of robust IP protection for biopharma innovations before WTO and in current and future FTAs
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 15, 2025
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- ALTRIUS GROUP, LLC
- Client
- PFIZER INC
- Filing UUID
- 095eebb8-7950-4817-8328-2aa3fff327a4
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.